A. van Nieuwenhuijze

发表

The Molecular Control of Regulatory T Cell Induction.

A. Liston, A. van Nieuwenhuijze, 2015, Progress in molecular biology and translational science.

Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.

I. Wicks, A. van Nieuwenhuijze, N. Sims, 2006, Arthritis and rheumatism.

GM-CSF as a therapeutic target in inflammatory diseases.

I. Wicks, A. van Nieuwenhuijze, W. B. van den Berg, 2013, Molecular immunology.

Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in r

I. Wicks, A. van Nieuwenhuijze, W. B. van den Berg, 2015, Arthritis Research & Therapy.

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis

J. Campbell, P. Tak, A. van Nieuwenhuijze, 2014, Annals of the rheumatic diseases.

GM‐CSF increases cross‐presentation and CD103 expression by mouse CD8+ spleen dendritic cells

I. Wicks, Yuekang Xu, A. van Nieuwenhuijze, 2011, European journal of immunology.

Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus

A. van Nieuwenhuijze, L. Aarden, R. Smeenk, 2003, Annals of the rheumatic diseases.

Transgenic expression of GM-CSF in T cells causes disseminated histiocytosis.

W. Alexander, I. Wicks, A. van Nieuwenhuijze, 2014, The American journal of pathology.

Soluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections.

H. V. van Houwelingen, A. van Nieuwenhuijze, L. Aarden, 1998, Blood.

Critical role for granulocyte colony-stimulating factor in inflammatory arthritis.

A. Roberts, I. Wicks, A. van Nieuwenhuijze, 2004, Proceedings of the National Academy of Sciences of the United States of America.

MicroRNA miR-29c regulates RAG1 expression and modulates V(D)J recombination during B cell development.

A. Liston, A. van Nieuwenhuijze, S. Raghavan, 2021, Cell reports.

CCR7 Modulates the Generation of Thymic Regulatory T Cells by Altering the Composition of the Thymic Dendritic Cell Compartment.

Angela M. Jarrett, T. Yankeelov, Y. Li, 2017, Cell reports.

A robust pipeline with high replication rate for detection of somatic variants in the adaptive immune system as a source of common genetic variation in autoimmune disease

Susan M. Schlenner, A. Goris, S. Mustjoki, 2018, Human molecular genetics.

Inflammatory Gene Expression Profile and Defective Interferon‐γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients

A. Goris, C. Wouters, A. Liston, 2017, Arthritis & rheumatology.

Differentiation of Inflammatory Dendritic Cells Is Mediated by NF-κB1–Dependent GM-CSF Production in CD4 T Cells

I. Wicks, S. Gerondakis, A. van Nieuwenhuijze, 2011, The Journal of Immunology.

Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.

I. Wicks, H. Scott, D. Tarlinton, 2009, Arthritis and rheumatism.

The Th17 Pathway as a Therapeutic Target in Rheumatoid Arthritis and Other Autoimmune and Inflammatory Disorders

A. van Nieuwenhuijze, W. B. van den Berg, M. Koenders, 2013, BioDrugs.

Elevated nucleosome levels in systemic inflammation and sepsis*

B. Lämmle, C. Hack, A. van Nieuwenhuijze, 2003, Critical care medicine.

Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis.

I. Wicks, A. van Nieuwenhuijze, P. Egan, 2008, Arthritis and rheumatism.

GM-CSF as a therapeutic target in inflammatory diseases.

I. Wicks, A. van Nieuwenhuijze, W. B. van den Berg, 2013, Molecular immunology.